Modifier -25 use in dermatology
Alam, M.
Cutis 95(2): 76-77
2015
ISSN/ISBN: 0011-4162 PMID: 25750960 Document Number: 679916
Document emailed within 1 workday
Related Documents
Parish, L.C. 1986: Dermatology and venereology in Italy 100 years ago. Relations with American and German dermatology and venereology. I: Dermatology Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 121(4): 243-246Henning, J.S.; Firoz, B.F. 2010: Combat dermatology: the prevalence of skin disease in a deployed dermatology clinic in Iraq Journal of Drugs in Dermatology: Jdd 9(3): 210-214
Abedini, R.; Matinfar, A.; Sasani, P.; Salehi, A.; Daneshpazhooh, M. 2017: Evaluation of Patients Visiting the Dermatology Emergency Unit of a University Dermatology Hospital in Tehran, Iran Acta Medica Iranica 55(11): 705-711
Savarise, M.T.; Senkowski, C.K.; Romano, T.; Nagle, J. 2016: Modifier 25 under fire: Are you using it correctly? Bulletin of the American College of Surgeons 101(12): 65-68
Maillard, F. 1994: Pidotimod. A new biological response modifier. Introduction Arzneimittel-Forschung 44(12a): 1399-1401
Legrum, W.; Stuehmeier, G.; Netter, K.J. 1979: Cobalt as a modifier of microsomal monooxgenases in mice Toxicology and Applied Pharmacology 48(2): 195-204
Tyring, S. 2001: Imiquimod applied topically: A novel immune response modifier Skin Therapy Letter 6(6): 1-4
Majima, H.; Nomura, K. 1986: Phase i clinical study of MY-1, a new biological response modifier Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(1): 109-115
Berman, B.; Poochareon, V.N.; Villa, A.M. 2002: Novel dermatologic uses of the immune response modifier imiquimod 5% cream Skin Therapy Letter 7(9): 1-6
Spencer, H.G.; Barnett, J.A. 1996: Mutation-selection balance at a modifier-of-imprinting locus Genetics 144(1): 361-367
Pérez Redondo, R.; Bustamante, J.; de Paz, J.A. 2002: Physical activity as modifier of renal function. Historical review Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 22(1): 15-23
Guerra, S.; Sherrill, D.L.; Cottini, M.; Michetti, G.; Allegra, L. 2002: On the association between date of birth and pollen sensitization: is age an effect modifier? Allergy and Asthma Proceedings 23(5): 303-310
Shoham-Yakubovich, I.; Barell, V. 1988: Maternal education as a modifier of the association between low birthweight and infant mortality International Journal of Epidemiology 17(2): 370-377
Rutledge, B.J.; Mortin, M.A.; Schwarz, E.; Thierry-Mieg, D.; Meselson, M. 1988: Genetic interactions of modifier genes and modifiable alleles in Drosophila melanogaster Genetics 119(2): 391-397
Gould, K.A.; Luongo, C.; Moser, A.R.; McNeley, M.K.; Borenstein, N.; Shedlovsky, A.; Dove, W.F.; Hong, K.; Dietrich, W.F.; Lander, E.S. 1996: Genetic evaluation of candidate genes for the Mom1 modifier of intestinal neoplasia in mice Genetics 144(4): 1777-1785
Cheng, Y.; Wu, W.; Zhang, D.-q.; Mai, Y.-z. 2010: Enzyme-catalyzed synthesis of ASGPR ligand-targeted modifier in non-aqueous medium Yao Xue Xue Bao 45(9): 1134-1138
Miller, A.; Joondeph, B.; Peyman, G.A.; Fiscella, R. 1988: Intravitreal toxicity of bovine cartilage extract (Catrix-S): a biologic response modifier Annals of Ophthalmology 20(3): 100
Pagel, P.S.; Hettrick, D.A.; Montgomery, M.W.; Kersten, J.R.; Warltier, D.C. 1998: RSR13, a synthetic allosteric modifier of hemoglobin, enhances recovery of stunned myocardium in dogs Advances in Experimental Medicine and Biology 454: 527-531
Matsunaga, K.; Morita, I.; Oguchi, Y.; Fujii, T.; Yoshikumi, C.; Nomoto, K. 1987: The effect of a biological response modifier, PSK, on the intestinal immune system in tumor-bearing mice Anticancer Research 7(3 Part B): 509-512
Ferreira, M-José.U.; Duarte, Nélia.; Gyémánt, N.; Radics, R.; Cherepnev, G.; Varga, A.; Molnár, J. 2006: Interaction between doxorubicin and the resistance modifier stilbene on multidrug resistant mouse lymphoma and human breast cancer cells Anticancer Research 26(5a): 3541-3546